Dr Samantha Barton
NHMRC
Australia
The Role of Oligodendrocytes in Frontotemporal Dementia
NHMRC
417,271
01/01/16
5.0
Alzheimer's disease & other dementias
frontotemporal dementia | oligodendrocytes | neurodegeneration | stem cell transplantation | stem cells
Dementia affects 35.6 million people world-wide; this number is projected to double every 20 years. Frontotemporal dementia (FTD) is the second most common type and has been found to have similar cause and pathology to common neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We ultimately require treatments to slow, stop and repair the damaged brain of FTD patients and this is only possible by understanding the mechanisms involved in the onset and progression of disease.